
Rtnew LF 80mg/480mg Tablet
Marketer
Dr Arvind Lifescience Pvt Ltd
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Rtnew LF 80mg/480mg Tablet
Malarone LF 80mg/480mg tablets effectively treat malaria in patients of all ages. This combination antimalarial medication targets the malaria parasite, halting infection progression. However, it's unsuitable for malaria prevention or severe cases involving organ complications (brain, lungs, kidneys). Optimal absorption requires ingestion with food. Always adhere to your physician's prescribed dosage and duration; exceeding the recommended amount can be detrimental. Complete the entire course for thorough treatment. Common side effects include headache, decreased appetite, fatigue, arthralgia, and myalgia; dizziness may also occur. Report persistent or worsening symptoms to your doctor. Prior to use, disclose all current medications to your doctor. Use during pregnancy or breastfeeding requires explicit medical approval due to potential fetal harm.
Primary Ingredients of Rtnew LF 80mg/480mg Tablet
No text was provided to rewrite.
Uses of Rtnew LF 80mg/480mg Tablet
Managing Malaria Infections
Major Benefits of Rtnew LF 80mg/480mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume the Rtnew LF 80mg/480mg Tablet with a meal.
Common Side effects of Rtnew LF 80mg/480mg Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Rtnew LF 80mg/480mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Administer the Rtnew LF 80mg/480mg Tablet with a meal.
How Rtnew LF 80mg/480mg Tablet works:
Artemether and lumefantrine, combined as Rtnew LF 80mg/480mg tablets, provide effective antimalarial therapy. Their mechanism involves elevating blood heme concentrations, a process toxic to the malaria parasite, thus eliminating the parasite and halting disease progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rtnew LF 80mg/480mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rtnew LF 80mg/480mg Tablet during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing it. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on current evidence, the use of Rtnew LF 80mg/480mg tablets while breastfeeding is likely safe. Available data from human studies indicate minimal risk to the infant.
DrivingUNSAFE
Taking Rtnew LF 80mg/480mg tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
The use of Rtnew LF 80mg/480mg tablets requires careful consideration in individuals with severely impaired kidney function. A modified dosage of Rtnew LF 80mg/480mg tablets might be necessary. Physician consultation is advised. Dosage alteration is not typically advised for those with severe kidney disease.
LiverCAUTION
The use of Rtnew LF 80mg/480mg tablets requires careful consideration in individuals with severe hepatic impairment. Dosage modification of Rtnew LF 80mg/480mg tablets might be necessary. Physician consultation is advised. Dosage alterations are not typically advised for patients with severely compromised liver function.
What if you forget to take Rtnew LF 80mg/480mg Tablet :
Should you forget to take a Rtnew LF 80mg/480mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rtnew LF 80mg/480mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimalarial Medications |
